MCRB SERES THERAPEUTICS INC Disposals and divestitures 8-K Filing 2024 - Financial Disclosure Seres Therapeutics is providing its audited financial statements for the fiscal years 2022 and 2023, which are consistent with previous reports, for use in a proxy statement related to the sale of assets from its VOWST microbiome therapeutic business.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC